The body armor market is not large by industrial standards, but in 2026 it is unusually difficult to buy in. Two forces are reshaping how professional buyers evaluate and price certified armor at the same time: a federal standard mid-overhaul, and a tariff regime that has changed three times in five months. For procurement teams responsible for outfitting officers, security contractors, or corporate protective details, the practical questions are no longer only about protection levels. They are about how to read a certification claim that may not mean what it says, and how to price a product whose landed cost is moving underneath the quote.
The market in numbers
Market researchers put the global body armor market at roughly $3 billion in 2026, with most forecasts projecting mid-single-digit annual growth, in the region of 6 percent, through the end of the decade. The composition matters more than the headline figure. Defense and law enforcement still account for the large majority of demand, but the civilian and private-security segment is the fastest-growing slice, expanding faster than the market as a whole as direct-to-consumer channels and private security expand. North America remains the largest regional market, which means US standards and US trade policy exert outsized influence on what gets made and what it costs.
That growth profile is stable enough. What is not stable is the two-part disruption sitting on top of it.
The standards shift, and why it is a procurement problem
The National Institute of Justice published Standard 0101.07 in November 2023, the first full revision of the federal body armor standard since 2008. For buyers, three changes matter. The familiar Roman numeral levels (IIA through IV) are being retired in favor of plainer designations: HG for handgun-rated soft armor and RF for rifle-rated hard plates. The standard adds RF2, a genuinely new intermediate rifle tier tested against 5.56mm M855 at roughly 3,115 feet per second, which formalizes the gap that manufacturers previously filled with unofficial “III+” labels. And it tightens testing, adding edge-shot conditioning and improved test methods for armor designed for women.
Here is the fact that governs procurement in 2026: the standard is live, but the certification list is not. As of mid-2026, no body armor model has yet been listed on the 0101.07 Compliant Products List. NIJ has said it will not publish a thin or unbalanced list prematurely, and has indicated that listings should begin appearing during 2026. Until they do, the 0101.06 Compliant Products List, which NIJ has committed to maintaining through at least the end of 2027, remains the authoritative record of independently verified armor. Agencies are not forced to re-equip, and armor certified under 0101.06 is fully current. The problem is that the marketing has run ahead of the certifications. Across trade floors in 2026, “0101.07 ready” and “RF2 capable” claims appear frequently, at exactly the moment buyers have the least ability to verify them.
How to read certification claims during the transition
This is where a buyer’s diligence earns its keep, because the language is doing a lot of quiet work. Three tiers of claim are circulating, and they are not equivalent.
The strongest is “NIJ Listed.” It means a model passed the Compliance Testing Program at an approved laboratory, received a Notice of Compliance, and appears on the public CPL, where it is subject to follow-up inspection testing on samples bought off the shelf. The middle tier is “tested to” or “designed to meet” 0101.07 parameters. That means a named laboratory ran the new threat profile against the product, which is useful, but it is not a CPL listing and carries no follow-up surveillance. The weakest is “0101.07 certified,” a phrase no manufacturer can currently substantiate, because there is no 0101.07 CPL to be listed on. Treat “+” designations such as III+ or RF2+ the same way: they are manufacturer labels, not NIJ threat levels.
The operational rule follows directly. Verify every model against the live NIJ Compliant Products List rather than accepting a slogan on a spec sheet, and for any 0101.07 claim, require the named laboratory’s test report rather than a marketing designation. Because the terminology is shifting mid-cycle, procurement teams also need a working grasp of how the body armor industry structures its certification tiers, enough to separate a CPL listing from a lab test and to brief non-specialist stakeholders, legal, and finance accurately during the changeover. The buyers who get burned in this window will be the ones who paid a premium for a label rather than a listing.
The tariff variable
The second disruption is cost, and its timeline is genuinely volatile. In 2025 the administration imposed broad tariffs under the International Emergency Economic Powers Act. On February 20, 2026, the Supreme Court held that IEEPA does not authorize tariffs and struck them down. Within hours, the administration replaced them with a temporary surcharge underSection 122 of the Trade Act of 1974, initially 10 percent and raised to the statutory maximum of 15 percent two days later, effective February 24.
That surcharge has since been challenged and is itself contested. The Court of International Trade ruled it unlawful on May 7, 2026, but the Federal Circuit stayed that ruling on June 11, finding the government likely to prevail, so collection continues on most imports. The surcharge is scheduled to lapse 150 days after it took effect, on July 24, 2026, but buyers should not budget for relief: the administration has signaled it intends to replace it with country-specific duties under Section 301, and separate Section 232 tariffs on steel and aluminum were never affected by any of this.
For the ballistic supply chain, the exposure is concrete. Imported aramid fiber, ultra-high-molecular-weight polyethylene, ceramic strike faces, and finished foreign-made armor all sit within the surcharge’s reach, which pushes landed costs up and makes lead times harder to quote with confidence. There is a cash-flow wrinkle as well: while courts have directed that the invalidated IEEPA duties be refunded, the mechanism is not yet automated, so money already paid on earlier orders may not return quickly and should not be counted on in near-term budgets. Domestically produced armor, including Berry-compliant product bound for federal buyers, is comparatively insulated, which is worth weighing where continuity of supply is mission-critical. The practical steps are unglamorous but they protect margins: get pricing and lead times fixed in writing, document any tariff-driven increases for budget justification, and track the July expiry and the Section 301 pipeline rather than assuming the current rate is the settled one.
What this means for buyers
The two disruptions pull in the same direction. On the standards side, the safe move is to treat the live CPL as the single source of truth and to decline any premium attached to a “0101.07” claim that cannot be verified there yet. On the cost side, the safe move is to assume continued tariff pressure through at least the second half of 2026 and to build that uncertainty into contracts rather than into hope. The one genuine advantage in this market is time. Because the 0101.06 list stands through 2027, buyers are not forced to react to either the marketing or the tariff cliff on a compressed schedule. They can plan replacement cycles deliberately, verify claims against primary sources, and model tariff exposure line by line. In a $3 billion market growing steadily but buffeted by policy, that discipline, not the newest label on the box, is what separates a sound purchase from an expensive one.
